Rasna Therapeutics
New York, US · Founded 2012 · Nevada corporation
Founders & leadership
JT
James TrippExecutive
TL
Tiziano LazzarettiExecutive
Board
JA
John Alex MartinBoard director
JM
Jim MervisBoard director
JB
John BrancaccioBoard director
RD
Riccardo Dalla-FaveraBoard director
AP
Alessandro PadovaBoard director
KS
Kunwar ShailubhaiBoard director
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2016
▶$2MraisedDec 2016 · 5 investors · BiotechnologyRule 506(b)
▶$2MraisedDec 2016 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John Alex MartinDirector
- James TrippExecutive Officer, Director
- Jim MervisDirector
- Tiziano LazzarettiExecutive Officer
- John BrancaccioDirector
- Riccardo Dalla-FaveraDirector
- Alessandro PadovaDirector
- Kunwar ShailubhaiDirector
- Offering amount
- $10M
- Amount sold
- $2M
- Minimum investment
- $25K
- First sale
- Dec 2016
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Rasna Therapeutics raised?
- Rasna Therapeutics has disclosed $2M raised across 1 round.
- Where is Rasna Therapeutics headquartered?
- Rasna Therapeutics is headquartered in New York, US.